INTERNATIONAL PATENT: ALIGOS THERAPEUTICS, INC. FILES APPLICATION FOR "MODIFIED ANTISENSE OLIGONUCLEOTIDES FOR TREATING HEPATITIS B VIRUS"

GENEVA, Nov. 25 -- ALIGOS THERAPEUTICS, INC. (1 Corporate Drive, 2nd FloorSouth San Francisco, California 94080) filed a patent application (PCT/US2025/029182) for "MODIFIED ANTISENSE OLIGONUCLEOTIDES FOR TREATING HEPATITIS B VIRUS" on May 13, 2025. With publication no. WO/2025/240506, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RAJWANSHI, Vivek K. (c/o ALIGOS THERAPEUTICS, INC.1 Corporate Drive, 2nd FloorSouth San Francisco, California 94080), HONG, Jin (c/o ALIGOS THERAPEUTICS, INC.1 Corporate Drive, 2nd FloorSouth ...